華興資本控股(01911.HK)盈喜:預計上半年純利同比增長約194%
格隆匯7月28日丨華興資本控股(01911.HK)公佈,集團預期於截至2021年6月30日止六個月錄得公司擁有人應占利潤約12億人民幣,而於2020年同期錄得公司擁有人應占利潤約4.07億人民幣,顯著增長約194%。
集團於截至2021年6月30日止六個月的利潤增長主要由於(i)集團首次公開發售項目承銷能力穩步攀升,尤其在於截至2021年6月30日止六個月內的香港資本市場當中表現突出,且建立了穩健的項目儲備;(ii)集團的投資管理業務對私募股權基金的管理持續為集團帶來投資收益;及(iii)華興證券有限公司於截至2021年6月30日止六個月扭虧為盈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.